Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Hüll

Showing results (41-50 of 48) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 48 results.
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139M Hüll, B L Fiebich, P Dykierek, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|August 26, 2009
[Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis]G Rehor, A Conca, W Schlotter, et al.
European Journal of Neurology|October 18, 2011
Dementia quality of life instrument--construct and concurrent validity in patients with mild to moderate dementiaS Voigt-Radloff, R Leonhart, M Schützwohl, et al.
The Journal of Nutrition, Health & Aging|June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCIO Peters, D Lorenz, A Fesche, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Pageof 5

Showing results (41-50 of 48) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 48 results.
European Archives of Psychiatry and Clinical Neuroscience|September 5, 1998
Early-onset Alzheimer's disease due to mutations of the presenilin-1 gene on chromosome 14: a 7-year follow-up of a patient with a mutation at codon 139M Hüll, B L Fiebich, P Dykierek, et al.
Neuropsychiatrie : Klinik, Diagnostik, Therapie Und Rehabilitation : Organ Der Gesellschaft Osterreichischer Nervenarzte Und Psychiater|August 26, 2009
[Relapse rate within 6 months after successful ECT: a naturalistic prospective peer- and self-assessment analysis]G Rehor, A Conca, W Schlotter, et al.
European Journal of Neurology|October 18, 2011
Dementia quality of life instrument--construct and concurrent validity in patients with mild to moderate dementiaS Voigt-Radloff, R Leonhart, M Schützwohl, et al.
The Journal of Nutrition, Health & Aging|June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCIO Peters, D Lorenz, A Fesche, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Molecular Psychiatry|March 16, 2016
Genome-wide significant risk factors for Alzheimer's disease: role in progression to dementia due to Alzheimer's disease among subjects with mild cognitive impairmentA Lacour, A Espinosa, E Louwersheimer, et al.
Pageof 5